XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.25.2

Summary of Significant Accounting Policies - Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive (Details) | 6 Months Ended
--- | ---
Jun. 30, 2025 USD ($) shares
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 632,119
Standard Conversion Common Stock Equivalent | 605,894
Liquidation Amount (in Dollars) | $ | $ 36,724,253
Series A Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding |
Standard Conversion Common Stock Equivalent |
Liquidation Amount (in Dollars) | $ |
Series A-1 Convertible Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 21,803
Standard Conversion Common Stock Equivalent | 2,456
Liquidation Amount (in Dollars) | $ | $ 27,253,448
Series B Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding |
Standard Conversion Common Stock Equivalent |
Liquidation Amount (in Dollars) | $ |
Series B-1 Convertible Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 2,689
Standard Conversion Common Stock Equivalent | 332
Liquidation Amount (in Dollars) | $ | $ 3,361,250
Series B-2 Convertible Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 2,625
Standard Conversion Common Stock Equivalent | 279
Liquidation Amount (in Dollars) | $ | $ 3,281,250
Series C Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding |
Standard Conversion Common Stock Equivalent |
Liquidation Amount (in Dollars) | $ |
Series C-1 Convertible Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 2,263
Standard Conversion Common Stock Equivalent | 88
Liquidation Amount (in Dollars) | $ | $ 2,828,305
Series D-1 Preferred Stock [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding |
Standard Conversion Common Stock Equivalent |
Liquidation Amount (in Dollars) | $ |
Warrants [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 602,680
Standard Conversion Common Stock Equivalent | 602,680
Liquidation Amount (in Dollars) | $ |
Options [Member] |
Schedule of Dilutive Earnings Per Share as Effects Were Anti-Dilutive [Line Items] |
Quantity Issued and Outstanding | 59
Standard Conversion Common Stock Equivalent | 59
Liquidation Amount (in Dollars) | $ |

X
- Definition Represent the amount of standard conversion common stock equivalent value. + References No definition available. + Details
Name: | adtx_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLiquidationAmount
Namespace Prefix: | adtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares quantity issued and outstanding. + References No definition available. + Details
Name: | adtx_QuantityIssuedAndOutstanding
Namespace Prefix: | adtx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B + Details
Name: | us-gaap_EarningsPerShareDilutedLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_SeriesA1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_SeriesB1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_SeriesB2ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesCPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_SeriesC1ConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_SeriesD1PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=adtx_OptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |